Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Curis Inc

CRIS
3,3359
0,1159 (3,60%)
Ultimo aggiornamento: 20:26:22
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/2/202514:00EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
30/1/202522:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202522:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202522:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202522:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202522:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202522:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202522:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202414:38EDGAR2Form S-3 - Registration statement under Securities Act of..
10/12/202414:00PRNUSCuris Announces Additional Data from TakeAim Leukemia Study
14/11/202414:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202414:03EDGAR2Form 8-K - Current report
14/11/202414:00PRNUSCuris Provides Third Quarter 2024 Business Update
07/11/202414:00PRNUSCuris to Report Third Quarter 2024 Financial and Operating..
01/11/202421:35EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
30/10/202411:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/10/202402:59EDGAR2Form 8-K - Current report
29/10/202411:04PRNUSCuris Announces $12.1 Million Registered Direct and..
29/10/202402:50EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
23/9/202414:30PRNUSCuris Announces the 3rd Annual Symposium on IRAK4 in Cancer
17/9/202413:30PRNUSCuris to Participate at the Upcoming 2024 Cantor Fitzgerald..
04/9/202414:00PRNUSCuris to Present at Upcoming Healthcare Conferences in..
01/8/202414:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202414:05EDGAR2Form 8-K - Current report
01/8/202414:00PRNUSCuris Provides Second Quarter 2024 Financial and Operating..
25/7/202414:00PRNUSCuris to Report Second Quarter 2024 Financial and Operating..
10/7/202413:30PRNUSCuris to Present at Upcoming Healthcare Conference in July
08/7/202413:30PRNUSCuris Reports Inducement Grants Under NASDAQ Listing Rule..
14/6/202422:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/5/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202422:06EDGAR2Form 8-K - Current report
14/5/202422:04EDGAR2Form 8-K - Current report
14/5/202422:00PRNUSCuris Announces Additional Data from TakeAim Leukemia Study
10/5/202414:00PRNUSCuris to Present Updated Data from the TakeAim Leukemia..
07/5/202414:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202414:02EDGAR2Form 8-K - Current report
07/5/202414:00PRNUSCuris Provides First Quarter 2024 Business Update
30/4/202414:00PRNUSCuris to Release First Quarter 2024 Financial Results and..
05/4/202413:30PRNUSCuris Reports Inducement Grants Under NASDAQ Listing Rule..
04/4/202413:30PRNUSCuris to Present at Upcoming Healthcare Conferences in April
Apertura: 3,27 Min: 3,26 Max: 3,4094
Chiusura: 3,22

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network